Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Livedo Vasculitis”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Early research (Phase 1)Study completedNCT00700518
What this trial is testing

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Procris Pharmaceuticals 10
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Not applicableStudy completedNCT02615964
What this trial is testing

Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.

Who this might be right for
Raynaud's Disease
University of Illinois at Chicago 5
Large-scale testing (Phase 3)Study completedNCT00266669
What this trial is testing

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 200
Large-scale testing (Phase 3)Study completedNCT01291199
What this trial is testing

Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome

Who this might be right for
Raynaud Syndrome
University of Cologne 57
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableEnded earlyNCT02642146
What this trial is testing

Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study

Who this might be right for
Raynaud DiseaseSystemic SclerosisDigital Ulcer
Seoul National University Hospital 71
Not applicableStudy completedNCT02202291
What this trial is testing

Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon

Who this might be right for
Primary Raynaud's Phenomenon (PR)Genetic Mutations Causing PRStudy of Patients and Their Relatives (With or Without Primary PR)
Nantes University Hospital 258
Not applicableUnknownNCT02183779
What this trial is testing

PORH and Response to Cold in Raynaud's Phenomenon.

Who this might be right for
Raynaud DiseaseHyperemiaCold
University Hospital, Grenoble 60
Very early researchStudy completedNCT02583789
What this trial is testing

Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Brigham and Women's Hospital 12
Post-approval studies (Phase 4)Looking for participantsNCT07112183
What this trial is testing

Open Label Treprostinil Raynaud's Study

Who this might be right for
Raynaud's DiseaseRaynaud PhenomenaRaynauds
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02551042
What this trial is testing

CSL Behring Sclero XIII

Who this might be right for
Systemic Sclerosis
University College, London 26
Large-scale testing (Phase 3)Study completedNCT00000530
What this trial is testing

Raynaud's Treatment Study (RTS)

Who this might be right for
Cardiovascular DiseasesHeart DiseasesRaynaud's Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT04015193
What this trial is testing

Follow-up of SPTS in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Medical Center Groningen 50
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Not applicableUnknownNCT05204784
What this trial is testing

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud PhenomenonDigital Ulcer+1 more
Peter Korsten 30
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Testing effectiveness (Phase 2)WithdrawnNCT06460194
What this trial is testing

Treatment of Frostbite Sequelae With Botulinum Toxin A

Who this might be right for
Cold HypersensitivityVascular System InjuriesVibration; Disorder+2 more
University Hospital of North Norway
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748000
What this trial is testing

LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Liquidia Technologies, Inc. 75
Next Page